IRIS
AVERSA, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.652
AS - Asia 14.087
EU - Europa 7.346
SA - Sud America 1.665
AF - Africa 670
Continente sconosciuto - Info sul continente non disponibili 328
OC - Oceania 9
Totale 38.757
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.176
SG - Singapore 5.347
CN - Cina 3.787
VN - Vietnam 1.783
IE - Irlanda 1.492
BR - Brasile 1.304
IT - Italia 1.260
HK - Hong Kong 1.019
SE - Svezia 916
FI - Finlandia 903
DE - Germania 779
BD - Bangladesh 700
TR - Turchia 698
ZA - Sudafrica 485
UA - Ucraina 435
FR - Francia 434
NL - Olanda 407
CA - Canada 328
GB - Regno Unito 194
RU - Federazione Russa 177
AR - Argentina 145
IN - India 137
IQ - Iraq 87
JP - Giappone 83
MX - Messico 76
AT - Austria 69
PL - Polonia 57
KR - Corea 51
EC - Ecuador 50
PH - Filippine 49
BE - Belgio 45
ES - Italia 42
VE - Venezuela 40
ID - Indonesia 39
PK - Pakistan 39
UZ - Uzbekistan 38
CO - Colombia 36
TH - Thailandia 36
CI - Costa d'Avorio 30
SA - Arabia Saudita 30
MA - Marocco 28
EG - Egitto 26
PY - Paraguay 26
CZ - Repubblica Ceca 24
EU - Europa 22
RO - Romania 21
TW - Taiwan 21
CL - Cile 20
KE - Kenya 19
LT - Lituania 19
JO - Giordania 16
PE - Perù 15
IL - Israele 14
SN - Senegal 12
BO - Bolivia 11
DZ - Algeria 11
OM - Oman 11
UY - Uruguay 11
CR - Costa Rica 10
GT - Guatemala 10
JM - Giamaica 10
NP - Nepal 10
PA - Panama 10
AE - Emirati Arabi Uniti 9
AL - Albania 9
AZ - Azerbaigian 9
ET - Etiopia 9
KZ - Kazakistan 9
SC - Seychelles 9
MY - Malesia 8
BG - Bulgaria 7
IR - Iran 7
KG - Kirghizistan 7
PS - Palestinian Territory 7
TN - Tunisia 7
GR - Grecia 6
BY - Bielorussia 5
DO - Repubblica Dominicana 5
GY - Guiana 5
HN - Honduras 5
NG - Nigeria 5
PT - Portogallo 5
QA - Qatar 5
SI - Slovenia 5
AO - Angola 4
AU - Australia 4
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
CH - Svizzera 4
GA - Gabon 4
KH - Cambogia 4
NZ - Nuova Zelanda 4
RS - Serbia 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BN - Brunei Darussalam 3
CG - Congo 3
CM - Camerun 3
DK - Danimarca 3
HU - Ungheria 3
Totale 38.381
Salva come PNG Salva come JPEG
Città #
Singapore 2.528
Dublin 1.492
Chandler 1.468
San Jose 1.418
Ashburn 1.402
Beijing 1.028
Hong Kong 979
Jacksonville 909
Izmir 623
Council Bluffs 585
Santa Clara 560
Ho Chi Minh City 530
Dallas 529
Nanjing 480
Johannesburg 461
Boardman 428
Hanoi 414
Dearborn 382
Princeton 352
New York 334
San Mateo 330
Lauterbourg 313
Parma 304
Los Angeles 267
Columbus 237
Wilmington 237
Ann Arbor 236
Toronto 198
Helsinki 158
Shenyang 154
Shanghai 151
Kunming 144
Nanchang 141
The Dalles 141
Moscow 135
Hebei 115
São Paulo 111
Buffalo 110
Jinan 100
Milan 98
Munich 97
Hefei 96
Changsha 93
Des Moines 93
Tianjin 86
Rome 85
Haiphong 81
Jiaxing 80
Da Nang 72
Tokyo 65
Düsseldorf 59
Guangzhou 56
Vienna 56
San Francisco 49
Seattle 49
Bologna 46
Frankfurt am Main 46
Norwalk 46
Orem 43
Turku 42
Atlanta 40
Chicago 40
Warsaw 40
Montreal 39
Brooklyn 38
London 37
Brussels 36
Hangzhou 36
Rio de Janeiro 35
Tashkent 35
Hải Dương 34
Boston 32
Belo Horizonte 31
Zhengzhou 31
Chennai 30
Abidjan 29
Chengdu 29
Kocaeli 29
Biên Hòa 28
Brasília 28
Marseille 28
Naples 28
Piscataway 28
Woodbridge 28
Phoenix 27
Stockholm 27
Charlotte 26
Denver 26
Jakarta 26
Houston 25
Secaucus 25
Falls Church 24
Bremen 23
Seoul 23
Baghdad 22
Dhaka 22
Fremont 21
Mestre 21
Mexico City 21
Wuhan 21
Totale 23.091
Salva come PNG Salva come JPEG
Nome #
BORTEZOMIB WITH HIGH DOSE MELPHALAN CONDITIONING FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IS SAFE AND IMPROVES THE RESPONSE RATE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA 306
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 261
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 230
Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma 223
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 221
Neurofibromatosis type I and multiple myeloma coexistence: A possible link? 212
The -2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severity 209
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 206
Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients. 205
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis 201
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 198
The Proteasome and Myeloma-Associated Bone Disease 192
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma 190
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo 187
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 186
Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20 185
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 183
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation 183
The -2518 A/G single nucleotide polymorphism of MCP-1 in myelofibrosis: functional characterization on ex-vivo patient cells. 182
Sindrome preleucemica 181
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 181
IN VITRO CHARACTERISTICS OF HEMATOPOIETIC PROGENITORS FROM PRIMARY MYELOFIBROSIS PATIENTS CORRELATE WITH IPSS/DIPSS RISK CATEGORY 181
Hypoxia-Inducible Factor (HIF)-1 alpha Inhibitionin Myeloma Cells Significantly Increases the Anti-Myeloma Effect of Lenalidomide in Vivo 180
EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA 176
PROTEIN KINASE Ce EXPRESSION IN PRIMARY MYELOFIBROSIS PLATELETS CORRELATES WITH CARDIOVASCULAR EVENTS 174
Addition of Bortezomib to High Dose Melphalan As Conditioning Regimen for Autologous Stem Cell Transplantation Improves the Response Rate in Newly Diagnosed Multiple Myeloma Patients 173
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. 169
''Designed'' grafts for HLA-haploidentical stem cell transplantation 168
ERK1/2 is the signaling pathway primarily activated in myeloid neoplasms carrying t(8;9)/PCM1-JAK2 fusion. A two cases report. 166
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 163
Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression 162
DEPENDENCE ON GLUTAMINE UPTAKE OF MYELOMA CELLS DELINEATES A NEW ATTRACTIVE THERAPEUTIC STRATEGY 162
Bortezomib improves bone integrity in multiple myeloma patients by blocking osteocyte death and autophagy 161
LENALIDOMIDE INCREASES HUMAN DENDRITIC CELL MATURATION MODULATING BOTH MONOCYTE DIFFERENTIATION AND MESENCHYMAL STROMAL CELL INHIBITORY PROPERTIES 161
Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin? 159
Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells 158
A prospective survey of febrile events in hematological malignancies 158
[Evaluation of the immunological status of patients with Hodgkin's disease] 157
GOOD IMMUNOLOGICAL RECONSTITUTION IN ADULTS WITH ACUTE LEUKEMIA AFTER.LFA-BETA TCR/CD19+DEPLETED HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) 157
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 156
Protein kinase Cɛ inhibition restores megakaryocytic differentiation of hematopoietic progenitors from primary myelofibrosis patients 155
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 155
Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. 154
Expression Profile of CD38 and Related Ectoenzymes in Myeloma Bone Niche: A Rational Basis for the Use of Daratumumab to Inhibit Osteoclast Formation and Activity 154
Acquisition of Ig isotype diversity after bone marrow transplantation in adults. A recapitulation of normal B cell ontogeny. 152
Platelet expression of PKCepsilon oncoprotein in myelofibrosis is associated with disease severity and thrombotic risk 152
Lung damage following bone marrow transplantation after hyperfractionated total body irradiation. 151
[Sequential polychemotherapeutic treatment of inoperable bronchogenic carcinoma] 151
Back to the future: mismatched unrelated donor, haploidentical related donor, or unrelated umbilical cord blood transplantation? 150
Galectin-1 Is Highly Expressed By Myeloma Cells and the Bone Marrow Microenvironment and Its Suppression Delineates a New Therapeutic in Vitro and in Vivo Strategy in Multiple Myeloma 149
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 148
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia. 148
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. 148
The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells 148
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties 147
Acute lymphoblastic leukaemia in Noonan syndrome. 146
TLR3 essentially promotes protective class I-restricted memory CD8⁺ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. 145
PCM1-JAK2 Fusion Product Selectively Activates MAP-Kinase Pathway and Fails to Phosphorylate JAK2 and STAT5: Implications for Therapeutic Strategies. 144
Bone marrow CD14+ cells show different transcriptional profiles in Multiple Myeloma (MM) as compared to smoldering MM and MGUS: overexpression of IL21R and its involvement in osteoclastogenesis 142
The link between bone microenvironment and immune cells in multiple myeloma: Emerging role of CD38 141
Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide 141
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients. 141
Haploidentical stem cell transplantation after negative depletion of T cells expressing the alfabeta chain of the T-cell receptor (TRC) for adults with haematological malignamcies 140
The osteoblastic niche in the context of multiple myeloma 139
Serie granulocitaria 138
Primary Prophylaxis of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Revised Recommendations from a Consensus Process by Gruppo Italiano Trapianto Midollo Osseo (GITMO) 136
A multidrug-resistant Pseudomonas aeruginosa isolate from a lethal case of sepsis induces necrosis of human neutrophils. 136
Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Modulating Both Monocyte Differentiation and Mesenchymal Stromal Cell Inhibitory Properties through Ikaros and Casein Kinase 1 Degradation, Respectively 135
Etiology of febrile episodes in patients with acute myeloid leukemia: results from the Hema e-Chart Registry 134
Allogeneic Hematopoietic stem cell transplantation and natural killer cell alloreactivity, 134
Human thrombopoiesis depends on PKCdelta/PKCepsilon functional couple 134
Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation. 132
Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group. 132
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 131
Protein Kinase C Epsilon Inhibition Restores In-Vitro Megakaryocyte Differentiation Of Primary Myelofibrosis Hematopoietic Progenitors 131
Amphotericin B lipid complex in the management of invasive fungal infections in immunocompromised patients 130
T cell depleted haploidentical transplantation: positive selection. 130
A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients. 130
Oncolytic Virotherapy in Multiple Myeloma: A Possible Alternative Role of Bovine Viruses 130
Microbiota control of a tryptophan–AhR pathway in disease tolerance to fungi 130
T cell depleted HLA-identical bone marrow transplants 129
Baseline factors associated with response to ruxolitinib: An independent study on 408 patients with myelofibrosis 129
Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies. 128
Mieloma multioplo ed altre discrasie linfoplasmacellulari 127
The anti-myeloma effect of Lenalidomide is increased by hypoxia-inducible factor (HIF)-1a inhibition in multiple myeloma cells both in vitro and in vivo 127
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 127
Hypoxia-inducible factor (HIF)-1 is a therapeutic target in myeloma-induced angiogenesis and bone destruction in vitro and in vivo 126
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 126
[T-cell depletion today: pros and cons] 125
Peripheral blood progenitor cell mobilization in healthy donors receiving recombinant human granulocyte colony-stimulating factor. 124
Allogeneic transplants of rhG-CSF-mobilized peripheral blood stem cells (PBSC) from normal donors. GITMO. Gruppo Italiano Trapianto di Midollo Osseo. 124
Favorable clinical outcome and response to immunotherapy share a common PD-L1/PD-1 based NSCLC immune contexture 124
T Cell Responses in Fungal Infections 123
Amiloidosi 123
Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation. 123
Therapeutic Strategy for Elderly Patients with ACUTE Myeloid Leukemia (AML) Carrying the DNMT3A Mutation 123
Non-B, non-T acute lymphoblastic leukaemia terminating in malignant histiocytosis: a new case and a review of the literature. 122
Allogeneic transplantation across the HLA barriers. 122
The haploidentical option for high-risk haematological malignancies. 121
Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma 121
Totale 15.621
Salva come PNG Salva come JPEG
Categoria #
all - tutte 138.815
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.815
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.493 0 15 17 64 45 28 170 257 62 197 85 553
2022/20235.299 688 350 244 381 463 586 60 352 1.913 35 165 62
2023/20241.800 128 230 53 60 155 515 68 116 25 68 144 238
2024/20256.419 62 398 520 413 640 424 182 367 838 627 605 1.343
2025/202614.485 1.107 1.277 1.810 1.038 2.185 781 1.812 455 1.652 931 785 652
2026/20271.084 411 673 0 0 0 0 0 0 0 0 0 0
Totale 38.757